| Date Filed | Type | Description |
| 06/09/2023 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 4,049 shares
@ $20.04, valued at
$81.1k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/25/2023 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Granted 138,200 options to buy
@ $22.02, valued at
$3M
|
|
| 12/16/2022 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 2,066 shares
@ $30.66, valued at
$63.3k
Sold 387 shares
@ $31.23, valued at
$12.1k
|
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2020 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $21.5697, valued at
$107.8k
|
|
| 08/04/2020 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 250,000 options to buy
@ $21.06, valued at
$5.3M
|
|
| 08/04/2020 |
3
| Goeltz II Robert C. (CFO) has filed a Form 3 on Arcus Biosciences, Inc. |
| 06/24/2020 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Paid exercise price by delivering 2,483 shares
@ $9.67, valued at
$24k
|
|
| 04/01/2020 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 29,106 shares
@ $0
Granted 118,188 options to buy
@ $5.95, valued at
$703.2k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2019 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 28,814 options to buy
@ $3.43, valued at
$98.8k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2018 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Converted 1,630 shares
@ $0
Converted 1,630 preferred shares
@ $0 |
|
| 05/04/2018 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 30,508 options to buy
@ $17, valued at
$518.6k
|
|
| 05/02/2018 |
3
| Goeltz II Robert C. (CFO) has filed a Form 3 on Unity Biotechnology, Inc. |
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2016 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $4.4728, valued at
$17.9k
|
|